Literature DB >> 19950248

Passage in egg culture is a major cause of apparent positive selection in influenza B hemagglutinin.

Derek Gatherer1.   

Abstract

Several studies have identified residues apparently under positive selection in influenza B virus hemagglutinin. Host immune evasion is the main mechanism proposed to exert this selection pressure. However, these reports have not considered the culture history of the strains used to calculate positive selection. This article shows that passage of influenza B virus through egg culture is a strong contributory factor to the strength and statistical significance of positive selection on hemagglutinin. Non-synonymous mutations resulting in the loss of the N-glycosylation site at positions 197-199 of hemagglutinin have been positively selected to a far greater degree in egg-cultured strains than in other strains. Once egg-cultured strains are removed from the analysis, positive selection is found to be far weaker, less statistically significant, and more diffusely localized along the protein. Caution should therefore be exercised both in claims for the existence of positive selection in influenza B hemagglutinin, and in attribution of host immune evasion as its cause. The major cause of molecular adaptation in influenza B hemagglutinin proteins may well be laboratory eggs rather than natural hosts. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950248     DOI: 10.1002/jmv.21648

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Tempo and mode in the molecular evolution of influenza C.

Authors:  Derek Gatherer
Journal:  PLoS Curr       Date:  2010-11-30

2.  Sequence amplification via cell passaging creates spurious signals of positive adaptation in influenza virus H3N2 hemagglutinin.

Authors:  Claire D McWhite; Austin G Meyer; Claus O Wilke
Journal:  Virus Evol       Date:  2016-10-03

3.  Genome-wide evolutionary dynamics of influenza B viruses on a global scale.

Authors:  Pinky Langat; Jayna Raghwani; Gytis Dudas; Thomas A Bowden; Stephanie Edwards; Astrid Gall; Trevor Bedford; Andrew Rambaut; Rodney S Daniels; Colin A Russell; Oliver G Pybus; John McCauley; Paul Kellam; Simon J Watson
Journal:  PLoS Pathog       Date:  2017-12-28       Impact factor: 6.823

Review 4.  The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?

Authors:  Brian J Ward; Stephane Pillet; Nathalie Charland; Sonia Trepanier; Julie Couillard; Nathalie Landry
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

5.  Influenza A Hemagglutinin Passage Bias Sites and Host Specificity Mutations.

Authors:  Raphael T C Lee; Hsiao-Han Chang; Colin A Russell; Marc Lipsitch; Sebastian Maurer-Stroh
Journal:  Cells       Date:  2019-08-22       Impact factor: 6.600

6.  Development of high-yield influenza A virus vaccine viruses.

Authors:  Jihui Ping; Tiago J S Lopes; Chairul A Nidom; Elodie Ghedin; Catherine A Macken; Adam Fitch; Masaki Imai; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

7.  Influenza B viruses in pigs, Taiwan.

Authors:  Ching-Ping Tsai; Hsiang-Jung Tsai
Journal:  Influenza Other Respir Viruses       Date:  2018-10-27       Impact factor: 4.380

8.  Cell-Adapted Mutations and Antigenic Diversity of Influenza B Viruses in Missouri, 2019-2020 Season.

Authors:  Cynthia Y Tang; Karen Segovia; Jane A McElroy; Tao Li; Minhui Guan; Xiaojian Zhang; Shamita Misra; Jun Hang; Xiu-Feng Wan
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.